» Articles » PMID: 34069830

Cardiac Autonomic Dysfunction in Myasthenia Gravis and Relapsing-Remitting Multiple Sclerosis-A Pilot Study

Overview
Journal J Clin Med
Specialty General Medicine
Date 2021 Jun 2
PMID 34069830
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

This study assessed cardiac autonomic response to head-up tilt test (HUTT) in 23 myasthenia gravis (MG) and 23 relapsing-remitting multiple sclerosis (RRMS) patients compared to 30 healthy controls (HC). Task Force Monitor was used to evaluate cardiac inotropy parameters, baroreflex sensitivity (BRS), heart rate (HRV), and blood pressure variability (BPV) during HUTT. MG patients were characterized by reduced BRS ( < 0.05), post-HUTT decrease in high-frequency component ( < 0.05) and increase in sympathovagal ratio of HRV ( < 0.05) when compared to controls indicating parasympathetic deficiency with a shift of sympathovagal balance toward sympathetic predominance. Compared to HC, MG patients also showed lower cardiac inotropy parameters, specifically, left ventricular work index (LVWI) during supine rest ( < 0.05) as well as LVWI and cardiac index values in response to orthostatic stress ( < 0.01 and < 0.05, respectively). Compared to controls, RRMS patients were characterized by lower HRV delta power spectral density ( < 0.05) and delta low-frequency HRV ( < 0.05) in response to HUTT suggesting combined sympathetic and parasympathetic dysfunction. There were no differences in cardiac autonomic parameters between MG and MS patients ( > 0.05). Our study highlights the possibility of cardiac and autonomic dysfunction in patients with MG and RRMS which should be considered in the pharmacological and rehabilitation approach to managing these conditions.

Citing Articles

Diurnal cognitive functioning in patients with myasthenia gravis with the role of chronotype and depression: a pilot study.

Wilkosc-Debczynska M, Liberacka-Dwojak M, Rzepinski L, Gilhus N Postep Psychiatr Neurol. 2024; 33(2):49-53.

PMID: 39119548 PMC: 11304226. DOI: 10.5114/ppn.2024.141051.


Frequency and severity of autonomic dysfunction assessed by objective hemodynamic responses and patient-reported symptoms in individuals with myasthenia gravis.

Zawadka-Kunikowska M, Cieslicka M, Klawe J, Tafil-Klawe M, Kazmierczak W, Rzepinski L Front Neurosci. 2024; 18:1415615.

PMID: 39099636 PMC: 11295281. DOI: 10.3389/fnins.2024.1415615.


Comparative Analysis of Serum Amino Acid Profiles in Patients with Myasthenia Gravis and Multiple Sclerosis.

Koslinski P, Rzepinski L, Koba M, Maciejek Z, Kowalewski M, Daghir-Wojtkowiak E J Clin Med. 2024; 13(14).

PMID: 39064122 PMC: 11277976. DOI: 10.3390/jcm13144083.


Correlation between Cardiovascular Autonomic and Pulmonary Ventilation Functions in Myasthenia Gravis Patients.

Zawadka-Kunikowska M, Rzepinski L, Cieslicka M, Fanslau J, Klawe J, Tafil-Klawe M Adv Respir Med. 2023; 91(6):546-559.

PMID: 38131875 PMC: 10740449. DOI: 10.3390/arm91060040.


Altered Cardiac Autonomic Regulation in Individuals with Myasthenia Gravis-A Systematic Review and Meta-Analysis.

Zawadka-Kunikowska M, Rzepinski L, Tafil-Klawe M, Veronese N, Barbagallo M, Habek M Neurol Int. 2023; 15(3):1140-1154.

PMID: 37755362 PMC: 10537350. DOI: 10.3390/neurolint15030071.


References
1.
Gatta V, Mengod G, Reale M, Tata A . Possible Correlation between Cholinergic System Alterations and Neuro/Inflammation in Multiple Sclerosis. Biomedicines. 2020; 8(6). PMC: 7345633. DOI: 10.3390/biomedicines8060153. View

2.
Steiner D, Plaugher G, Alcantara J . Chiropractic management of a patient with myasthenia gravis and vertebral subluxations. J Manipulative Physiol Ther. 1999; 22(5):333-40. DOI: 10.1016/s0161-4754(99)70066-7. View

3.
Shukla G, Gupta S, Goyal V, Singh S, Srivastava A, Behari M . Abnormal sympathetic hyper-reactivity in patients with myasthenia gravis: a prospective study. Clin Neurol Neurosurg. 2012; 115(2):179-86. DOI: 10.1016/j.clineuro.2012.05.013. View

4.
Kaegi C, Wuest B, Schreiner J, Steiner U, Vultaggio A, Matucci A . Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders. Front Immunol. 2019; 10:1990. PMC: 6743223. DOI: 10.3389/fimmu.2019.01990. View

5.
Tsiptsios D, Fotiou D, Haidich A, Brozou G, Nakou M, Giantselidis C . Evaluation of pupil mobility in patients with myasthenia gravis. Electromyogr Clin Neurophysiol. 2008; 48(5):209-18. View